ANIXA BIOSCIENCES, INC. Revenue, Net (Deprecated 2018-01-31)
ANIXA BIOSCIENCES, INC. (ANIX) reported Revenue, Net (Deprecated 2018-01-31) of $300.00 thousand for the 12-month period ending 2016-10-31, per its 10-K filed 2016-12-08.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2016-12-08
- ANIXA BIOSCIENCES, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2016-10-31 was $200.00K.
- ANIXA BIOSCIENCES, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2016-07-31 was $100.00K, a 5.26% increase year-over-year.
- ANIXA BIOSCIENCES, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2015-10-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2015-07-31 was $95.00K, a 92.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $300.00K, a 96.76% decline from fiscal 2015.
- ANIXA BIOSCIENCES, INC. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $9.26M, a 152.36% increase from fiscal 2014.
- ANIXA BIOSCIENCES, INC. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $3.67M, a 843.12% increase from fiscal 2013.
- ANIXA BIOSCIENCES, INC. revenue, net (deprecated 2018-01-31) for fiscal 2013 was $388.85K, a 58.63% decline from fiscal 2012.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2016-10-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $300.00K derived: sum of 2 quarters · filed 2016-12-08 | $300.00K 10-K · filed 2016-12-08 | ||
| 2016-07-31 | $100.00K 10-Q · filed 2016-08-19 | $100.00K 10-Q · filed 2016-08-19 | |||
| 2015-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $95.00K derived: sum of 2 quarters · filed 2016-12-08 | $120.00K derived: sum of 3 quarters · filed 2016-12-08 | $9.26M 10-K · filed 2016-12-08 | |
| 2015-07-31 | $95.00K 10-Q · filed 2016-08-19 | $120.00K derived: sum of 2 quarters · filed 2016-08-19 | $9.26M 10-Q · filed 2016-08-19 | $10.63M derived: sum of 4 quarters · filed 2016-08-19 | |
| 2015-04-30 | $25.00K 10-Q · filed 2016-05-20 | $9.16M 10-Q · filed 2016-05-20 | $10.54M derived: sum of 3 quarters · filed 2016-05-20 | $11.72M derived: sum of 4 quarters · filed 2016-05-20 | |
| 2015-01-31 | $9.13M 10-Q · filed 2016-02-19 | $10.51M derived: sum of 2 quarters · filed 2016-02-19 | $11.70M derived: sum of 3 quarters · filed 2016-02-19 | $12.80M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-10-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $2.56M derived: sum of 2 quarters · filed 2015-12-23 | $3.67M derived: sum of 3 quarters · filed 2015-12-23 | $3.67M 10-K · filed 2015-12-23 | |
| 2014-07-31 | $1.19M 10-Q · filed 2015-08-18 | $2.29M derived: sum of 2 quarters · filed 2015-08-18 | $2.29M 10-Q · filed 2015-08-18 | ||
| 2014-04-30 | $1.10M 10-Q · filed 2015-05-22 | $1.10M 10-Q · filed 2015-05-22 | |||
| 2013-10-31 | $386.72K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-01-29 | $386.72K derived: sum of 2 quarters · filed 2015-01-29 | $386.72K derived: sum of 3 quarters · filed 2015-01-29 | $388.85K 10-K · filed 2015-01-29 | |
| 2013-07-31 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | $0.00 derived: sum of 2 quarters · filed 2013-09-20 | $2.13K 10-Q/A · filed 2013-09-20 | $2.48K derived: sum of 4 quarters · filed 2013-09-20 | |
| 2013-04-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | $2.13K 10-Q/A · filed 2013-06-19 | $2.48K derived: sum of 3 quarters · filed 2013-06-19 | $251.95K derived: sum of 4 quarters · filed 2013-09-20 | |
| 2013-01-31 | $2.13K 10-Q/A · filed 2013-03-25 | $2.48K derived: sum of 2 quarters · filed 2013-03-25 | $251.95K derived: sum of 3 quarters · filed 2013-09-20 | $500.02K derived: sum of 4 quarters · filed 2013-09-20 | |
| 2012-10-31 | $350.00 10-K · filed 2013-01-29 | $249.82K derived: sum of 2 quarters · filed 2013-09-20 | $497.89K derived: sum of 3 quarters · filed 2013-09-20 | $940.01K 10-K/A · filed 2014-01-17 | $947.09K 10-K · filed 2013-01-29 |
| 2012-07-31 | $249.47K 10-Q/A · filed 2013-09-20 | $497.54K derived: sum of 2 quarters · filed 2013-09-20 | $946.74K 10-Q/A · filed 2013-09-20 | $1.40M derived: sum of 4 quarters · filed 2013-09-20 | |
| 2012-04-30 | $248.07K 10-Q/A · filed 2013-06-19 | $697.26K 10-Q/A · filed 2013-06-19 | $1.15M derived: sum of 3 quarters · filed 2013-06-19 | $1.60M derived: sum of 4 quarters · filed 2013-06-19 | |
| 2012-01-31 | $449.19K 10-Q/A · filed 2013-03-25 | $898.15K derived: sum of 2 quarters · filed 2013-03-25 | $1.35M derived: sum of 3 quarters · filed 2013-03-25 | $1.44M derived: sum of 4 quarters · filed 2013-03-25 | |
| 2011-10-31 | $448.96K 10-K · filed 2013-01-29 | $899.32K derived: sum of 2 quarters · filed 2013-01-29 | $986.24K derived: sum of 3 quarters · filed 2013-01-29 | $1.00M 10-K · filed 2013-01-29 | |
| 2011-07-31 | $450.36K 10-K · filed 2013-01-29 | $537.27K derived: sum of 2 quarters · filed 2013-01-29 | $554.23K 10-Q · filed 2012-09-14 | $865.48K derived: sum of 4 quarters · filed 2013-01-29 | |
| 2011-04-30 | $86.92K 10-K · filed 2013-01-29 | $103.87K 10-Q · filed 2012-06-14 | $415.12K derived: sum of 3 quarters · filed 2013-01-29 | $473.15K derived: sum of 4 quarters · filed 2013-01-29 | |
| 2011-01-31 | $16.96K 10-K · filed 2013-01-29 | $328.21K derived: sum of 2 quarters · filed 2013-01-29 | $386.24K derived: sum of 3 quarters · filed 2013-01-29 | ||
| 2010-10-31 | $311.25K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $369.28K derived: sum of 2 quarters · filed 2012-01-30 | $730.67K 10-K · filed 2012-01-30 | ||
| 2010-07-31 | $58.03K 10-Q/A · filed 2011-10-14 | $419.43K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |